Epax AS: Consumer Packaged Goods - Company Profile and SWOT Analysis

Summary
Canadean's "Epax AS: Consumer Packaged Goods - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, recent developments, key employees as well as company locations and subsidiaries.

Key Findings
This report is a crucial resource for industry executives and anyone looking to access key information about "Epax AS"

The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Synopsis
EPAX AS (EPAX) manufactures and distributes marine based omega-3 ingredients. The company offers its ingredients under two product lines: Epax Ultra Concentrates and Epax Core Concentrates. These ingredients find applications in pharmaceutical and nutraceutical products. Omega-3 fatty acids ingredients are used for curing a wide range of health problems including cardiovascular, cognitive, pre and postnatal, joint, mood and eye health disorders. The company sells its products under EPAX brand. The company distributes its products through FMC sales force, and through global network of local agents and distributors. It operates as a subsidiary of FMC Corporation, a diversified chemical company. EPAX is headquartered in Oslo, Norway.

- This business intelligence report presents the key company information, essential to understanding industry challenges and competitors.

- The SWOT analysis identifies the company's strengths, weaknesses, opportunities for growth and threats. The key competitors are dissected alongside the larger challenges that the industry is facing.

- The company profile relays all current information about the business operations, including key employees, major products and services, company history, locations and subsidiaries alongside a supporting statement from the Chairman and Managing Director.

Reasons?To?Buy
- Quickly enhance your understanding of "Epax AS"

- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.

- Increase business/sales activities by understanding your competitors' businesses better.

- Recognize potential partnerships and suppliers.

Key Highlights
EPAX AS (EPAX) manufactures and distributes marine based omega-3 ingredients. The company offers its ingredients under two product lines: Epax Ultra Concentrates and Epax Core Concentrates. These ingredients find applications in pharmaceutical and nutraceutical products. Omega-3 fatty acids ingredients are used for curing a wide range of health problems including cardiovascular, cognitive, pre and postnatal, joint, mood and eye health disorders. The company sells its products under EPAX brand. The company distributes its products through FMC sales force, and through global network of local agents and distributors. It operates as a subsidiary of FMC Corporation, a diversified chemical company. EPAX is headquartered in Oslo, Norway.

1 Epax AS
2 Epax AS - Key Employees
3 Epax AS - Major Products and Services
4 Epax AS - History
5 Epax AS - Locations and Subsidiaries
5.1 Epax AS - Head Office
6 Epax AS - Business Analysis
6.1 Epax AS - Company Overview
6.2 Epax AS - Business Description
7 Epax AS - SWOT Analysis
7.1 Epax AS - SWOT Analysis - Overview
7.2 Epax AS - Strengths
7.2.1 Strength - Focus on Quality and Food Safety
7.2.2 Strength - Focus towards Sustainability
7.3 Epax AS - Weaknesses
7.3.1 Weaknesses - Limited Product Portfolio
7.3.2 Weaknesses - Concentrated Operations
7.4 Epax AS - Opportunities
7.4.1 Opportunities - New Product Launches
7.4.2 Opportunities - Increasing Demand for Omega-3 Fatty Acids
7.4.3 Opportunities - Increase in Demand for Functional Food
7.5 Epax AS - Threats
7.5.1 Threats - Increasing Input Prices
7.5.2 Threats - Intense Competition
7.5.3 Threats - Increase in Counterfeit Products
8 Epax AS - Recent Developments
9 Appendix
9.1 Methodology
9.2 Disclaimer